Morgan Stanley Mauritius Company has sold 364,047 shares of Strides Arcolab in an open market transaction. The foreign fund house has sold the shares on Bombay Stock Exchange (BSE) at Rs 900.01 per share on March 12, 2013.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.